DATA SHEET - Medsafe
Serious infections associated with myelosuppression, including sepsis and pneumonia, have been reported. Patients who develop a new infection while undergoing treatment with sulfasalazine
Download DATA SHEET - Medsafe
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
Presentation, Advantan presentation uses, Advantan, Uses, Methylprednisolone aceponate, Methylprednisolone, Aceponate
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Draft, Good, Practices, Manufacturing, Edition, Edition draft, Good manufacturing practice
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
CIGNA 90 NOWSM MAINTENANCE DRUG LIST
www.myhealth360piedmont.comCIGNA 90 NOWSM MAINTENANCE DRUG LIST For customers who must fill their maintenance medications in a 90-day supply Your plan includes a new maintenance medication program called …
Drug, Maintenance, Lists, Cigna, Cigna 90 nowsm maintenance drug list, Nowsm
DRUGS TO AVOID IN G6PD DEFICIENCY - cych.org.tw
www.cych.org.twDRUGS TO AVOID IN G6PD DEFICIENCY DEFINITE RISK OF HAEMOLYSIS POSSIBLE RISK OF HAEMOLYSIS Pharmacological Class Drugs* Pharmacological Class Drugs* • ß-Naphthol
Drug, Deficiency, Avoid, Drugs to avoid in g6pd deficiency, G6pd
Patient Information Leaflet - Medicines
www.medicines.org.ukPage 2 of 10 Patient Information Leaflet Salazopyrin® EN-tabs 500 mg enteric-coated tablets sulfasalazine In this leaflet: 1. What Salazopyrin EN-tabs are and what they are used for
Photosensitizing Medication List - Vitiligo Support
www.vitiligosupport.orgt a n n i n g f a c t b o o k 2 0 0 8 / 2 0 0 9 c h a p t e r t w o 25 looking fit lookingfit.com Note: Items with an asterisk (*) are more likely
Lists, Medication, Photosensitizing, Photosensitizing medication list
The EULAR points to consider for use of antirheumatic ...
e-lactancia.orgThe EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation Carina Götestam Skorpen,1,2,3 Maria Hoeltzenbein,4 Angela Tincani,5 Rebecca Fischer-Betz,6 Elisabeth Elefant,7 Christina Chambers,8 Josè da Silva,9 Catherine Nelson-Piercy,10 Irene Cetin,11 Nathalie Costedoat-Chalumeau,12,13 Radboud Dolhain,14 Frauke Förger,15 Munther …
Drug, Before, Pregnancy, Antirheumatic, Of antirheumatic drugs before pregnancy
Sjögren’s Systemic Manifestations in Sjögren’s Patients ...
www.sjogrens.orgSSF16150.04S Sjögren’s Syndrome Foundation’s Clinical Practice Guidelines The Sjögren’s Syndrome Foundation (SSF) has developed the first U.S. Rheumatology Clinical
SALAZOPYRIN - Medsafe
www.medsafe.govt.nzSALAZOPYRIN® Tablets and EN tablets Sulfasalazine Consumer Medicine Information . What is in this leaflet stiffness in your joints. "Salazopyrin" will be used in this
Inflectra® (infliximab-dyyb) Injectable Medication ...
www.aetna.comGR-69299 (1-18) Inflectra ® (infliximab-dyyb) Injectable Medication Precertification Request . Page 3 of 4 (All fields must be completed and legible for Precertification Review.)
Medication, Request, Precertification, Injectable medication precertification request, Injectable, Infliximab, Infliximab dyyb, Dyyb
Azulfidine sulfasalazine tablets, USP DESCRIPTION
www.accessdata.fda.govAzulfidine ® sulfasalazine tablets, USP DESCRIPTION . AZULFIDINE Tablets contain sulfasalazine, 500 mg, for oral administration. Therapeutic Classification
Descriptions, Tablets, Sulfasalazine, Azulfidine sulfasalazine tablets, Azulfidine, Usp description, 174 sulfasalazine tablets
Related search queries
CIGNA 90 NOWSM MAINTENANCE DRUG LIST, DRUGS TO AVOID IN G6PD DEFICIENCY, Sulfasalazine, Photosensitizing Medication List, Of antirheumatic drugs before pregnancy, and, Infliximab-dyyb) Injectable Medication Precertification Request, Azulfidine sulfasalazine tablets, USP DESCRIPTION, Azulfidine ® sulfasalazine tablets, USP DESCRIPTION